These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer. Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Lee CY; Rennie PS; Jia WW Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction between oncolytic viruses augments tumor killing. Le Boeuf F; Diallo JS; McCart JA; Thorne S; Falls T; Stanford M; Kanji F; Auer R; Brown CW; Lichty BD; Parato K; Atkins H; Kirn D; Bell JC Mol Ther; 2010 May; 18(5):888-95. PubMed ID: 20234341 [TBL] [Abstract][Full Text] [Related]
7. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Leber MF; Bossow S; Leonard VH; Zaoui K; Grossardt C; Frenzke M; Miest T; Sawall S; Cattaneo R; von Kalle C; Ungerechts G Mol Ther; 2011 Jun; 19(6):1097-106. PubMed ID: 21468006 [TBL] [Abstract][Full Text] [Related]
9. Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Diallo JS; Vähä-Koskela M; Le Boeuf F; Bell J Methods Mol Biol; 2012; 797():127-40. PubMed ID: 21948474 [TBL] [Abstract][Full Text] [Related]
10. Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo. Connor JH; Naczki C; Koumenis C; Lyles DS J Virol; 2004 Sep; 78(17):8960-70. PubMed ID: 15308693 [TBL] [Abstract][Full Text] [Related]
11. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Qiao J; Wang H; Kottke T; Diaz RM; Willmon C; Hudacek A; Thompson J; Parato K; Bell J; Naik J; Chester J; Selby P; Harrington K; Melcher A; Vile RG Gene Ther; 2008 Apr; 15(8):604-16. PubMed ID: 18305577 [TBL] [Abstract][Full Text] [Related]
12. [Effect of apoptosis of vesicular stomatitis virus on tumor cells of nasopharyngeal carcinoma in vivo]. Feng Y; He G; Wu Y; Wen Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):995-7. PubMed ID: 19157153 [TBL] [Abstract][Full Text] [Related]
13. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus. Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242 [TBL] [Abstract][Full Text] [Related]
14. Virus specific tolerance enhanced efficacy of cancer immuno-virotherapy. Sobhanimonfared F; Bamdad T; Sadigh ZA; Choobin H Microb Pathog; 2020 Mar; 140():103957. PubMed ID: 31891795 [TBL] [Abstract][Full Text] [Related]
15. United virus: the oncolytic tag-team against cancer! Le Boeuf F; Bell JC Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326 [TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Hastie E; Cataldi M; Moerdyk-Schauwecker MJ; Felt SA; Steuerwald N; Grdzelishvili VZ Oncotarget; 2016 Sep; 7(38):61601-61618. PubMed ID: 27533247 [TBL] [Abstract][Full Text] [Related]
17. [Vesicular stomatitis virus in the fight against cancer]. Janelle V; Poliquin L; Lamarre A Med Sci (Paris); 2013 Feb; 29(2):175-82. PubMed ID: 23452604 [TBL] [Abstract][Full Text] [Related]
19. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes. Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo. Rognoni E; Widmaier M; Haczek C; Mantwill K; Holzmüller R; Gansbacher B; Kolk A; Schuster T; Schmid RM; Saur D; Kaszubiak A; Lage H; Holm PS Cancer Gene Ther; 2009 Oct; 16(10):753-63. PubMed ID: 19363467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]